Clinical Research Directory
Browse clinical research sites, groups, and studies.
Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis
Sponsor: China National Center for Cardiovascular Diseases
Summary
This study aims to evaluate, through a multicenter, prospective, double-blind, randomized, placebo-controlled clinical trial, whether immunosuppressive therapy improves target lesion-related cardiovascular outcomes compared to placebo treatment in patients with Rapid rEcurrence of Coronary Unexplained in-stent Restenosis (RECUR).
Official title: Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis (STOP-RECUR) Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
52
Start Date
2025-06-01
Completion Date
2028-06-01
Last Updated
2025-05-21
Healthy Volunteers
No
Conditions
Interventions
Immunosuppressive therapy
prednisone + sirolimus
Placebo
Placebo